ArticleFrontiers in oncology2026
Monte Carlo simulation and unfolding of an extended Bonner sphere system for secondary neutron spectrometry in proton therapy facilities using conventional BSS experimental data.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The extended-range Bonner Sphere Spectrometer (BSS) is a valuable tool for characterizing neutron fields in radiotherapy, including proton therapy facilities, where secondary neutrons contribute to the incidental dose received by the patient and staff. In this study we developed and validated a Monte Carlo (MC) model of an extended-range BSS by benchmarking against experimental measurements performed using a conventional BSS in a proton therapy facility. The extended-range system, which includes four additional spheres with aluminum and lead layers, was not available for this work; instead, simulations were validated against conventional BSS data and then applied to extrapolate the high-energy portion of the neutron spectrum. The MC simulations were performed using MCNP version 6.3 and include modelling of the BSS and using BSS response functions previously validated. The comparison in data trends between simulations and measurements confirms the reliability of the simulation model. The acquired neutron spectra show the characteristic shape, but also noticeable differences between the measurement locations in the intensity and width of the direct, evaporation, and thermal peaks. These differences are consistent with the changing measurement conditions in each case. The obtained spectra show similarity with other spectra available in literature. This work demonstrates that MC-modeled extended-range BSS can accurately characterize secondary neutron spectra in proton therapy facilities, providing a foundation for improved radiation protection and dose optimization studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.